Healthcare Webinars

Discover an informative webinar to explore shifting metabolic health trends, uncovering science-backed insights on wellness. The idea of health and what it means to be healthy has evolved significantly over the years. What was once assessed through standalone measurements is increasingly being viewed from a holistic outlook. Metabolic health, which is comprised of five key health markers, offers a comprehensive look at an individual’s overall health state and, because of this, is proving to be a better predictor of long-term wellness. One-quarter of the world’s population is affected by suboptimal metabolic health, with nearly 2 billion people worldwide being overweight. While lifestyle factors such as diet and exercise are essential to good metabolic health, changing how people live and eat can prove challenging. This is why many consumers are turning to science-backed supplement solutions to help aid them on their wellness journey. This highlights the opportunity for companies in the nutritional and dietary supplemental space to design innovative solutions that address the various aspects of metabolic health. While historically weight has been viewed as the key indicator of health, it is now known as the only piece of the larger wellness puzzle. To get a more complete picture, people must consider the additional markers that make up their metabolic fitness. Since metabolic health covers a broad range of factors beyond weight management, consumers want products they believe to be effective, backed by science, to meet their specific needs. Specialized products that aim to impact important attributes related to proper physiological and metabolic function are in demand. How concerned are consumers with the various areas of metabolic health? What solutions are they seeking? What actions are they taking? Join this webinar to learn about trends in metabolic health and formulating products that incorporate science-backed microbiome solutions and functional botanical ingredients.

Join us for an insightful webinar where real experiences and success stories present an innovative HPV screening solution. This webinar will feature the implementation of SEEGENE solutions, featuring HPV screening with 14 high-risk HPV types and SG STATS, which facilitates big data analysis. The speaker will highlight the remarkable progress made in cervical cancer screening in Lazio, Italy, sharing sincere firsthand accounts. Be a part of our exploration into the transformative impact of these advanced solutions, specifically in uplifting cervical cancer screening practices in Lazio.

Discover an informative webinar delving into how strategic oncology clinical trial design shapes success in early oncology studies using novel approaches. Trial design in early-phase oncology studies has a critical impact on the success of the study. Novel approaches such as biomarker stratification, adaptive enrichment designs, outcome-adaptive randomization and the integration of real-world data have been developed. In addition, under Project Optimus, dose expansion requires the selection of the most appropriate dose and schedule to be brought into the registrational trial, which also needs to be accomplished via dose-finding studies in early-phase trials. Attendees will learn insights into the trade-offs between protocol design options and offer insight into developing a trial structure that maximizes the chances of success in later phases of research while minimizing risk. Join this webinar to explore the intricate world of oncology trial design and gain valuable insights to enhance research approaches.

Discover an informative webinar discussing digital biomarkers in neuropsychiatric trials, leveraging an artificial intelligence (AI)-driven platform for enhanced treatment outcomes. Drugs for psychiatric conditions suffer some of the lowest approval rates when compared to other major therapeutic areas. Underlying factors can include complex and poorly understood etiology, which are heterogeneous in presentation, and underlying pathophysiology. Additionally, traditional clinical studies fail to objectively assess cognitive function as part of patient eligibility criteria or stratify patients according to the presence or degree of cognitive impairment. Cognitive function assessments and electroencephalogram (EEG) enable the measurement of pharmacodynamic endpoints in early-stage, translational psychiatric studies, however many studies do not leverage these tools today.

Discover an informative webinar exploring how streamlined interactive response technology (IRT) solutions simplify trials, cut costs and accelerate study initiation. Every clinical trial is distinct, with specific objectives and complexities. Similarly, choices for IRT systems can range from highly customizable platforms to more streamlined “express” solutions. In an increasingly complex clinical trial landscape, sponsors are often faced with balancing efficiency, budget constraints and trial complexity when choosing the most appropriate IRT solution. A sponsor might choose a streamlined or simplified version of IRT system for several reasons, depending on the specific circumstances of their clinical trial. The featured speakers will explore scenarios where this type of IRT system can lead to quicker trial initiation and cost savings. See how ICON Flex Advantage Express can support businesses as an economical IRT solution, where little to no customization is required. The speakers will demo how this tool provides IRT essentials such as screening, enrolment, randomization, dispensation, cohort management, emergency unblinding/reporting, notifications and integrations. They will also discuss optional services such as user acceptance testing (UAT) script writing and pack list/randomization list generation. Engage with the speakers and panel of experts for answers to specific questions about IRT solutions and to learn more about how a streamlined IRT system can benefit specific clinical trial needs. Key takeaways: Gain insights into the advantages of how a streamlined IRT solution can simplify clinical trials Learn when it’s ideal to opt for streamlined IRT and how it can align with study objectives See a demo of ICON’s Flex Advantage Express, an IRT solution that embodies the principles discussed during the webinar Embarking on a successful clinical trial journey requires the right tools and strategies and selecting the ideal IRT system is a critical step. Join this webinar to discover how streamlining IRT in clinical trials can help to achieve business goals for accelerated study initiation, greater cost containment and more efficient resource utilization, to ultimately support the overarching aim of bringing innovative treatments to patients sooner.

Join us for a webinar on “Treatable Traits for Long COVID”. Chaired by Professor Peter Gibson. Presenters include Dr. Hayley Lewthwaite, Professor Bruce Brew, and Associate Professor Anthony Byrne.

This 60-min webinar will provide an overview of the demographic shifts and the stressors that preceded the pandemic and the challenges that hospitals faced during this surge.

Presented by Douglas Austin Initially discovered in a Japanese man's ear in 2009, Candia auris has spread globally since then and has become a pathogen of concern. If invasive, this highly drug-resistant super fungus has a mortality rate of up to 34% and can quickly colonize patients throughout a facility. What can we do to tackle this emerging issue? This webinar discusses what Candida auris is, what we know about its transmission and the effect it has on hospitals and long-term care facilities.

The presentation is an introduction to the Feeling Safe Programme, which is a new cognitive-behavioral treatment for patients with psychosis. Developed with over a decade of research, it is the most effective psychological treatment for persecutory delusions. Half of the patients have recovered from their persecutory delusions with the Feeling Safe Programme.

Over the past two decades, the biopharmaceutical market has expanded, with monoclonal antibodies exhibiting a 26 percent higher approval rate than other drugs. Join this webinar to investigate the effects of simultaneously adjusting temperature and osmolality on the generation of host cell proteins (HCPs), antibody yield, and cell growth.